A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898
Status:
Terminated
Trial end date:
2017-08-23
Target enrollment:
Participant gender:
Summary
In this integrated, multi-part, Phase I study, the safety, tolerability, food effect,
pharmacokinetic (PK) and pharmacodynamic (PD) properties of single and repeated doses of
AZD9898 will be investigated.